Emrise Stock Price, News & Analysis (OTCMKTS:EMRI)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Emrise (OTCMKTS:EMRI)

EMRISE Corporation (EMRISE) designs, manufactures and markets electronic devices, sub-systems and equipment for aerospace, defense, industrial and communications markets. The Company’s products perform key functions such as power supply and power conversion; radio frequency (RF) and microwave signal conditioning; and network access and timing and synchronization of communications networks. It conducts its business through two operating segments: electronic devices and communications equipment. The Company’s two electronic devices segment business units, XCEL Power Systems Ltd. (XPS) and Pascall Electronics Limited (PEL), are located in the United Kingdom. The Company’s two communications equipment business units, CXR Larus Corporation (CXR Larus) and CXR Anderson-Jacobson (CXR AJ), are located in the United States and France, respectively.

Receive EMRI News and Ratings via Email

Sign-up to receive the latest news and ratings for EMRI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS$0.09
Net IncomeN/A
Net MarginsN/A
Return on Equity-26.51%
Return on Assets-11.60%


Outstanding SharesN/A

Emrise (OTCMKTS:EMRI) Frequently Asked Questions

What is Emrise's stock symbol?

Emrise trades on the OTCMKTS under the ticker symbol "EMRI."

Who are some of Emrise's key competitors?

How do I buy Emrise stock?

Shares of Emrise can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Emrise?

Emrise's mailing address is 2530 Meridian Pkwy, DURHAM, NC 27713-5272, United States. The company can be reached via phone at +1-408-2003040.

MarketBeat Community Rating for Emrise (EMRI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  31
MarketBeat's community ratings are surveys of what our community members think about Emrise and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Emrise (OTCMKTS:EMRI) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Emrise (OTCMKTS:EMRI) Earnings History and Estimates Chart

Earnings by Quarter for Emrise (OTCMKTS:EMRI)

Emrise (OTCMKTS EMRI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2015Q1 2015($0.06)ViewN/AView Earnings Details
3/31/2015Q4 2014$0.18ViewN/AView Earnings Details
11/14/2014Q3 2014$0.08ViewN/AView Earnings Details
8/19/2014Q2 2014($0.08)ViewN/AView Earnings Details
5/15/2014Q1 2014($0.07)ViewN/AView Earnings Details
4/15/2014Q4 2013$0.05ViewN/AView Earnings Details
11/14/2013Q3 2013($0.04)ViewN/AView Earnings Details
8/14/2013Q2 2013($0.01)ViewN/AView Earnings Details
5/13/2013($0.05)ViewN/AView Earnings Details
3/28/2013Q4 12$0.04ViewN/AView Earnings Details
11/14/2012Q3 2012$0.01ViewN/AView Earnings Details
8/14/2012Q2 2012$0.01ViewN/AView Earnings Details
5/15/2012Q1 2012($0.08)ViewN/AView Earnings Details
3/30/2012Q4 2011$0.03ViewN/AView Earnings Details
8/15/2011Q2 2011($0.11)ViewN/AView Earnings Details
5/16/2011Q1 2011($0.09)ViewN/AView Earnings Details
11/15/2010Q3 2010($0.02)ViewN/AView Earnings Details
8/16/2010Q2 2010($0.13)ViewN/AView Earnings Details
5/17/2010Q1 2010($0.16)ViewN/AView Earnings Details
11/16/2009Q3 2009($0.02)ViewN/AView Earnings Details
8/5/2009Q2 2009($0.05)ViewN/AView Earnings Details
5/14/2009Q1 2009($0.08)ViewN/AView Earnings Details
11/6/2008Q3 2008$0.03ViewN/AView Earnings Details
8/7/2008Q2 2008($0.03)ViewN/AView Earnings Details
5/15/2008Q1 2008($0.04)($0.09)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Emrise (OTCMKTS:EMRI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Emrise (OTCMKTS:EMRI)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Emrise (OTCMKTS EMRI) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Emrise (OTCMKTS:EMRI)

Emrise (OTCMKTS EMRI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2015Poplar Point Capital PartnersMajor ShareholderBuy163,351$1.12$182,953.12View SEC Filing  
6/7/2013Carmine T OlivaCEOBuy5,000$0.54$2,700.00View SEC Filing  
5/30/2013Frank P RussomannoDirectorBuy4,987$0.53$2,643.11View SEC Filing  
5/23/2013Julie AbrahamDirectorBuy5,000$0.54$2,700.00View SEC Filing  
12/11/2012Carmine T OlivaCEOBuy10,000$0.46$4,600.00View SEC Filing  
11/29/2012Frank P RussomannoDirectorBuy5,000$0.45$2,250.00View SEC Filing  
9/7/2012Graham JefferiesCOOBuy2,000$0.69$1,380.00View SEC Filing  
8/30/2012Julie AbrahamDirectorBuy5,000$0.70$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Emrise (OTCMKTS EMRI) News Headlines

No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Emrise (OTCMKTS:EMRI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Emrise (OTCMKTS EMRI) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.